Actively hiring
Bioinformatics
Biotechnology
Artificial Intelligence
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$6.8M
5 rounds on record
Latest round
$6.8M
Series B · Aug 2026 · 1 mo ago
Team
11-50
employees, estimated range
Grants
$3.1M
4 grants · CORDIS
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 18
Raised a round Series B $6.8M · EU-Startups
Jan 1, 2023
Won a grant $2.6M · CORDIS
Sep 1, 2020
Won a grant $106k · CORDIS
Dec 1, 2019
Won a grant $54k · CORDIS
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Oct 2026 | $298k | — | CORDIS |
| Series B | Aug 2026 | $6.8M | — | EU-Startups |
| Grant | Jan 2023 | $2.6M | — | CORDIS |
| Grant | Sep 2020 | $106k | — | CORDIS |
| Grant | Dec 2019 | $54k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Computomics GmbH | its site |
Similar startupsby what they do, their industry and backers

Turbine is virtualizing biological experiments with AI to accelerate drug discovery and enhance clinical translatability.

Endogene.bio generates high-resolution data from menstrual blood to accelerate disease understanding, patient stratification, and…

Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.

By testing every gene across all human tissues using large-scale Mendelian randomization and colocalization across thousands of diseases…

Tolemy — The AI-native virtual cell platform for therapeutic development and manufacture.

Discover 64xBio's end-to-end platform for next-generation biologics. We enable scalable therapeutic systems through VectorSelect™…
News
Deshalb wurde in Computomics investiert
Das Tübinger Unternehmen Computomics hat mehr als sechs Millionen Euro an frischem Kapital von Investoren und Förderprogrammen bekommen. Damit will Computomics den Einsatz von künstlicher Intelligenz in der Pflanzenzüchtung weiterentwickeln. SWR-Reporter
Read more
Report
Gravis Robotics erhält 200 Millionen - Computomicsbekommt 6,3 Millionen - Dash0 kauft Polar Signals
+++ #DealMonitor +++ Unicorn-Investment: Gravis Robotics erhält 200 Millionen +++ Computomicsbekommt 6,3 Millionen +++ Unicorn Dash0 kauft Polar Signals +++ get.de Partners setzt auf GoLeasy +++ accompio übernimmt techbold +++
Read more
Report
Germany's Computomics secures €6.3 million to help crop breeders stay ahead of heat and drought
Computomics, a Tübingen-based BioTech research company, has raised €6.3 million in a Series B round to scale commercial delivery of its climate-smart breeding platform, as heat and drought take an increasing toll on European harvests. The round was led by
Read more
Report
BASF Venture Capital, Amathaon Buy Minority Stake in Computomics
(PLX AI) - BASF Venture Capital and Amathaon Capital acquire minority stake in bioinformatics company Computomics. Existing shareholders include the seed investors High-Tech Gründerfonds (HTGF) and MBG
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Stuttgart
Germany
Registered seat
10-50 est. staff
